RG
Redmile Group’s Stoke Therapeutics STOK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $49.7M | Sell |
4,375,931
-110,050
| -2% | -$1.25M | 5.29% | 4 |
|
2025
Q1 | $29.8M | Sell |
4,485,981
-107,648
| -2% | -$716K | 2.82% | 12 |
|
2024
Q4 | $50.7M | Sell |
4,593,629
-119,880
| -3% | -$1.32M | 3.53% | 8 |
|
2024
Q3 | $57.9M | Sell |
4,713,509
-7,545
| -0.2% | -$92.7K | 3.41% | 7 |
|
2024
Q2 | $63.8M | Sell |
4,721,054
-351,995
| -7% | -$4.76M | 3.86% | 4 |
|
2024
Q1 | $68.5M | Buy |
5,073,049
+2,447,543
| +93% | +$33M | 2.51% | 10 |
|
2023
Q4 | $13.8M | Sell |
2,625,506
-1,247,190
| -32% | -$6.56M | 0.49% | 46 |
|
2023
Q3 | $15.3M | Sell |
3,872,696
-82,492
| -2% | -$325K | 0.73% | 33 |
|
2023
Q2 | $42M | Sell |
3,955,188
-190,208
| -5% | -$2.02M | 1.61% | 20 |
|
2023
Q1 | $34.5M | Buy |
4,145,396
+3,502,966
| +545% | +$29.2M | 1.5% | 23 |
|
2022
Q4 | $5.93M | Sell |
642,430
-193,400
| -23% | -$1.79M | 0.24% | 51 |
|
2022
Q3 | $10.7M | Sell |
835,830
-1,157,438
| -58% | -$14.9M | 0.42% | 50 |
|
2022
Q2 | $26.3M | Sell |
1,993,268
-31,100
| -2% | -$411K | 1.01% | 28 |
|
2022
Q1 | $42.6M | Sell |
2,024,368
-222,300
| -10% | -$4.68M | 1.33% | 20 |
|
2021
Q4 | $53.9M | Sell |
2,246,668
-135,290
| -6% | -$3.25M | 1.23% | 24 |
|
2021
Q3 | $60.6M | Sell |
2,381,958
-76,600
| -3% | -$1.95M | 1.06% | 32 |
|
2021
Q2 | $82.8M | Sell |
2,458,558
-85,504
| -3% | -$2.88M | 1.22% | 28 |
|
2021
Q1 | $98.8M | Sell |
2,544,062
-142,172
| -5% | -$5.52M | 1.39% | 23 |
|
2020
Q4 | $166M | Buy |
2,686,234
+136,728
| +5% | +$8.47M | 2.01% | 14 |
|
2020
Q3 | $85.4M | Buy |
2,549,506
+47,200
| +2% | +$1.58M | 1.57% | 20 |
|
2020
Q2 | $59.6M | Buy |
2,502,306
+336,368
| +16% | +$8.02M | 1.1% | 27 |
|
2020
Q1 | $49.6M | Buy |
2,165,938
+1,145,160
| +112% | +$26.2M | 1.39% | 24 |
|
2019
Q4 | $28.9M | Buy |
1,020,778
+3,300
| +0.3% | +$93.5K | 0.69% | 39 |
|
2019
Q3 | $21.9M | Sell |
1,017,478
-4,330
| -0.4% | -$93.1K | 0.73% | 42 |
|
2019
Q2 | $29.8M | Buy |
+1,021,808
| New | +$29.8M | 0.84% | 38 |
|